Toward practical standardization: Development of clinical common data elements for pediatric epilepsy in Korea and

Jaeso Cho1, Hee Jeong Yun2, Hyun Woo Kim2

  • 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, South Korea; Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea.

Seizure
|February 27, 2026
PubMed

Insights

Common data elements (CDEs) for pediatric epilepsy were developed and tested in Korean clinics. These CDEs proved feasible for collecting high-quality data, improving patient care and research.

Area of Science:

  • Neurology
  • Clinical Data Management
  • Pediatric Epilepsy Research

Background:

  • Pediatric epilepsy requires efficient data collection in time-limited clinical settings.
  • Existing frameworks may not be optimized for the specific needs of Korean pediatric epilepsy care.
  • Development of standardized data elements is crucial for research and clinical practice improvement.

Purpose of the Study:

  • To develop and evaluate common data elements (CDEs) for pediatric epilepsy in Korea.
  • To assess the feasibility and clinical utility of these CDEs in real-world clinical settings.
  • To tailor CDEs for time-limited clinical encounters.

Main Methods:

  • Multicenter development process involving expert discussions and review of existing data.
  • Retrospective and prospective testing of CDE templates across multiple tertiary hospitals.
  • Feasibility assessment through prospective application to pediatric epilepsy patients.

Main Results:

  • Developed feasible CDE templates for capturing baseline and longitudinal data in pediatric epilepsy.
  • Efficiently profiled a cohort of 1,096 patients, identifying key characteristics like developmental delay (33%) and drug-resistant epilepsy (30%).
  • Demonstrated clinical utility through subgroup comparisons and estimation of seizure-active periods (median 8.2-9.5 years).

Conclusions:

  • Pediatric epilepsy CDEs are feasible for use in time-limited clinical settings.
  • High-quality data collection is achievable, enhancing patient care.
  • The developed CDEs support research and clinical collaboration in pediatric epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
338
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
867